HEART ATRIAL MUSCARINIC RECEPTOR
HEART ATRIAL MUSCARINIC RECEPTOR
批准号:
2735058
负责人:
Michael Schimerlik
金额:
$30.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1980
资助国家:
美国
项目状态:
已结题
起止时间:
1980-12-01 至 2000-06-30
关键词:
CHO cells G protein atrium chemical binding circular dichroism cyclic AMP infrared spectrometry interferometry microorganism hemagglutinin molecular site muscarinic receptor phosphatidylinositols protein structure function receptor binding receptor coupling recombinant proteins site directed mutagenesis
中文摘要
M_2型乙酰胆碱受体亚型参与调节
由副交感神经系统控制心跳,这是很有趣的
作为抗心律失常药物的可能靶点。的长期目标是
这一建议是为了了解m2受体的分子机制。
尽可能详细的信号转导。重组M2
在中国仓鼠卵巢细胞中表达的受体提供了一个有用的系统
来实现这一目标。定点诱变与
研究结构/功能的配基结合和动力学方法
受体氨基酸与发展定量关系的研究
描述受体与配体结合方式的机制和
情侣对磷脂酰肌醇代谢的刺激和抑制
阵营的形成。重组蛋白也可以从
用于生物物理研究的足够数量的过表达细胞系
如远紫外圆二向色性和傅里叶变换红外
光谱分析受体结构。这些研究应该
有助于我们理解M2受体的结构和机制。
M_2受体信号转导的数量
透视并可能导致更合理的设计更有效
抗心律失常药。
英文摘要
The m2 muscarinic acetylcholine receptor subtype mediates the regulation
of the heartbeat by the parasympathetic nervous system and is of interest
as a possible target for antiarrhythmia drugs. The long-term objective of
this proposal is to understand the molecular mechanism of m2 receptor
signal transduction in as much detail as possible. The recombinant m2
receptor expressed in Chinese Hamster ovary cells provides a useful system
to accomplish this goal. Site-directed mutagenesis is combined with
ligand binding and kinetic approaches to examine structure/function
relationships for receptor amino acids and to develop quantitative
mechanisms describing the manner in which the receptor binds ligands and
couples to stimulation of phosphatidylinositol metabolism and inhibition
of cAMP formation. The recombinant protein can also be purified from
overexpressing cell lines in sufficient quantities for biophysical studies
such as far ultraviolet circular dichroism and Fourier transform infrared
spectroscopy to analyze receptor structure. These studies should
contribute to our understanding of m2 receptor structure and the mechanism
of m2 muscarinic receptor signal transduction from a quantitative
perspective and may result in the rational design of more effective
antiarrhythmic agents.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Structure and regulation of muscarinic receptors.
毒蕈碱受体的结构和调节。
DOI:
10.1146/annurev.ph.51.030189.001245
发表时间:
1989
期刊:
Annual review of physiology
影响因子:
18.2
作者:
[Schimerlik,MI]
通讯作者:
Schimerlik,MI
Multiple affinity states of different cholecystokinin receptors.
不同胆囊收缩素受体的多种亲和力状态。
DOI:
--
发表时间:
1994
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Huang,SC, Fortune,KP, Wank,SA, Kopin,AS, Gardner,JD]
通讯作者:
Gardner,JD
Partial agonist effects on the interaction between the atrial muscarinic receptor and the inhibitory guanine nucleotide-binding protein in a reconstituted system.
部分激动剂对重构系统中心房毒蕈碱受体和抑制性鸟嘌呤核苷酸结合蛋白之间相互作用的影响。
DOI:
--
发表时间:
1990
期刊:
Molecular pharmacology
影响因子:
3.6
作者:
[Tota,MR, Schimerlik,MI]
通讯作者:
Schimerlik,MI
Porcine m2 muscarinic acetylcholine receptor-effector coupling in Chinese hamster ovary cells.
中国仓鼠卵巢细胞中的猪 m2 毒蕈碱乙酰胆碱受体效应器偶联。
DOI:
10.1074/jbc.270.26.15485
发表时间:
1995
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Vogel,WK, Mosser,VA, Bulseco,DA, Schimerlik,MI]
通讯作者:
Schimerlik,MI
Maquiroside A, a new cytotoxic cardiac glycoside from Maquira calophylla.
Maquiroside A,一种来自 Maquira calophylla 的新型细胞毒性强心苷。
DOI:
10.1021/np50050a015
发表时间:
1987
期刊:
Journal of natural products
影响因子:
5.1
作者:
[Rovinski,JM, Tewalt,GL, Sneden,AT]
通讯作者:
Sneden,AT
共 24 条
Retinoic Acid Receptor: Dynamics, Stability, and Folding
-
批准号:7559170
-
项目类别:
-
资助金额:$22.16万
-
财政年份:2007
-
负责人:Michael Schimerlik
-
依托单位:
Retinoic Acid Receptors: Dynamics, Stability and Folding
-
批准号:6728285
-
项目类别:
-
资助金额:$17.69万
-
财政年份:2003
-
负责人:Michael Schimerlik
-
依托单位:
Retinoic Acid Receptors: Dynamics, Stability and Folding
-
批准号:7039105
-
项目类别:
-
资助金额:$17.27万
-
财政年份:2003
-
负责人:Michael Schimerlik
-
依托单位:
Retinoic Acid Receptors: Dynamics, Stability and Folding
-
批准号:6617171
-
项目类别:
-
资助金额:$17.69万
-
财政年份:2003
-
负责人:Michael Schimerlik
-
依托单位:
Retinoic Acid Receptors: Dynamics, Stability and Folding
-
批准号:6847442
-
项目类别:
-
资助金额:$17.69万
-
财政年份:2003
-
负责人:Michael Schimerlik
-
依托单位:
CORE--NUCLEIC ACIDS AND PROTEINS
-
批准号:6575639
-
项目类别:
-
资助金额:$7.89万
-
财政年份:2002
-
负责人:Michael Schimerlik
-
依托单位:
CHARACTERIZATION OF HEART ATRIAL MUSCARINIC RECEPTOR
-
批准号:3337349
-
项目类别:
-
资助金额:$23.13万
-
财政年份:1980
-
负责人:Michael Schimerlik
-
依托单位:
CHARACTERIZATION OF HEART ATRIAL MUSCARINIC RECEPTOR
-
批准号:3337341
-
项目类别:
-
资助金额:$2.68万
-
财政年份:1980
-
负责人:Michael Schimerlik
-
依托单位:
CHARACTERIZATION OF HEART ATRIAL MUSCARINIC RECEPTOR
-
批准号:3337348
-
项目类别:
-
资助金额:$22.34万
-
财政年份:1980
-
负责人:Michael Schimerlik
-
依托单位:
HEART ATRIAL MUSCARINIC RECEPTOR
-
批准号:2215676
-
项目类别:
-
资助金额:$27.45万
-
财政年份:1980
-
负责人:Michael Schimerlik
-
依托单位:
CHARACTERIZATION OF HEART ATRIAL MUSCARINIC RECEPTOR
-
批准号:3337339
-
项目类别:
-
资助金额:$22.56万
-
财政年份:1980
-
负责人:Michael Schimerlik
-
依托单位:
CHARACTERIZATION OF HEART ATRIAL MUSCARINIC RECEPTOR
-
批准号:3337342
-
项目类别:
-
资助金额:$2.78万
-
财政年份:1980
-
负责人:Michael Schimerlik
-
依托单位:
CHARACTERIZATION OF HEART ATRIAL MUSCARINIC RECEPTOR
-
批准号:3337345
-
项目类别:
-
资助金额:$15.99万
-
财政年份:1980
-
负责人:Michael Schimerlik
-
依托单位:
CHARACTERIZATION OF HEART ATRIAL MUSCARINIC RECEPTOR
-
批准号:3337343
-
项目类别:
-
资助金额:$11.64万
-
财政年份:1980
-
负责人:Michael Schimerlik
-
依托单位:
CHARACTERIZATION OF HEART ATRIAL MUSCARINIC RECEPTOR
-
批准号:3337347
-
项目类别:
-
资助金额:$17.35万
-
财政年份:1980
-
负责人:Michael Schimerlik
-
依托单位:
HEART ATRIAL MUSCARINIC RECEPTOR
-
批准号:2215677
-
项目类别:
-
资助金额:$26.9万
-
财政年份:1980
-
负责人:Michael Schimerlik
-
依托单位:
HEART ATRIAL MUSCARINIC RECEPTOR
-
批准号:2215679
-
项目类别:
-
资助金额:$28.03万
-
财政年份:1980
-
负责人:Michael Schimerlik
-
依托单位:
CHARACTERIZATION OF HEART ATRIAL MUSCARINIC RECEPTOR
-
批准号:3337338
-
项目类别:
-
资助金额:$15.26万
-
财政年份:1980
-
负责人:Michael Schimerlik
-
依托单位:
CHARACTERIZATION OF HEART ATRIAL MUSCARINIC RECEPTOR
-
批准号:3337346
-
项目类别:
-
资助金额:$17.97万
-
财政年份:1980
-
负责人:Michael Schimerlik
-
依托单位:
CHARACTERIZATION OF HEART ATRIAL MUSCARINIC RECEPTOR
-
批准号:3337344
-
项目类别:
-
资助金额:$16.55万
-
财政年份:1980
-
负责人:Michael Schimerlik
-
依托单位:
海外基金